Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Advion Sells 500th Compact Mass Spec. Extends Market Leadership.

Advion,Inc.
Posted on: 27 Sep 16

PR Newswire

ITHACA, N.Y., Sept. 27, 2016

ITHACA, N.Y., Sept. 27, 2016 /PRNewswire/ -- Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced that, during the quarter ending September 30, 2016, it had shipped its 500th Compact Mass Spec (CMS), with the milestone order having been received from a leading university in Taiwan, demonstrating the product's global appeal.  Demand for the product continues to accelerate, with nearly 200 units expected in 2016.

Commenting on the landmark, Advion's CEO David B. Patteson stated, "Having launched the product line about four years ago, we are exceedingly happy with the market adoption and product adaptation.  In 2012-2013, we quickly reached about 10 units per quarter. In 2014 we doubled to 20+/quarter.  In 2015, we exceeded 35/quarter, and this year we rose to 40-50/quarter and continue climbing. Equally rewarding are the workflow integration expansions and customer innovations.  We are routinely utilized in multiple modalities, and our easy-to-use CheMS software allows the chemist to choose, via software, which mode they desire without time-consuming setups, changeovers, plumbing or setting reconfigurations. Moreover, our customers have created novel ways to solve assay challenges; two such customer inventions made it to market in 2016:

  • The iASAP probe allows chemists to capture and assay, in an inert gas, previously impossible oxidizing inorganic complexes
  • The Volatile Sample System permits Breathomics and Headspace analysis

These are just two examples of creative customers using the CMS in a deployed lab to solve analytical problems, while working with our R&D team to bring solutions to the market for broad mutual benefit.  We see this continuing as our footprint expands."

Based upon publicly disclosed unit volumes from competitors, it is believed Advion enjoys between 75-85% market share in the synthetic organic, natural product and peptide discovery chemistry deployed lab market.  This position is expected to remain intact, if not grow, due to the company having signed a major OEM contract in Q4 2015, which should add between 30-40 units per annum beginning in October 2016.

About Advion, Inc.
Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfludics, we leverage our passionate employees' commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/advion-sells-500th-compact-mass-spec--extends-market-leadership-300334208.html

SOURCE Advion, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 27/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.